Cargando…
Cell-Based Therapy for Myocardial Dysfunction After Fontan Operation in Hypoplastic Left Heart Syndrome
Myocardial dysfunction after Fontan palliation for univentricular congenital heart disease is a challenging clinical problem. The medical treatment has a limited impact, with cardiac transplant being the ultimate management step. Cell-based therapies are evolving as a new treatment for heart failure...
Autores principales: | Qureshi, Muhammad Y., Cabalka, Allison K., Khan, Shakila P., Hagler, Donald J., Haile, Dawit T., Cannon, Bryan C., Olson, Timothy M., Cantero-Peral, Susana, Dietz, Allan B., Radel, Darcie J., Taggart, Nathan W., Kelle, Angela M., Rodriguez, Vilmarie, Dearani, Joseph A., O’Leary, Patrick W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134900/ https://www.ncbi.nlm.nih.gov/pubmed/30225415 http://dx.doi.org/10.1016/j.mayocpiqo.2017.07.002 |
Ejemplares similares
-
Fate of the Fontan connection: Mechanisms of stenosis and management
por: Hagler, Donald J., et al.
Publicado: (2019) -
Myocardial contractile response to dobutamine in hypoplastic left heart syndrome post-Fontan
por: Wong, James, et al.
Publicado: (2014) -
Recent outcomes of the extracardiac Fontan procedure in patients with hypoplastic left heart syndrome
por: Arunamata, Alisa, et al.
Publicado: (2020) -
Modeling of the Tricuspid Valve and Right Ventricle in Hypoplastic Left Heart Syndrome With a Fontan Circulation
por: Nam, Hannah H., et al.
Publicado: (2023) -
Right ventricular function and adaption after hemi-Fontan completion in children with hypoplastic left heart syndrome
por: Ruijsink, Bram, et al.
Publicado: (2016)